Pasar al contenido principal

COMPRENDER LA SINTESIS DEL ADN EN PATOGENOS BACTERIANOS: NUEVAS ESTRATEGIAS PARA EL TRATAMIENTO DE ENFERMEDADES INFECCIOSAS

RTI2018-098573-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

UPCommons. Portal del coneixement obert de la UPC
Publicación Artículo científico (JournalArticle)

Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability

  • Vukomanovic, Marija
  • Gazvoda, Lea
  • Kurtjak, Mario
  • Hrescak, Jitka
  • Jaklic, Blaz
  • Moya, Laura
  • Cendra Gascón, María del Mar|||0000-0002-2100-2406
  • Torrents Serra, Eduard
Designing useful functionalities in clinically validated, old antibiotics holds promise to provide the most economical solution for the global lack of effective antibiotics, as undoubtedly a serious health threat. Here we show that using the surface chemistry of the cyclodextrin (ßCD) cycle and arginine (arg) as a linker, provides more stable ternary antibiotic complex (ßCD-arg-cpx). In contrast to classical less stable inclusion complexes, which only modify antibiotic solubility, here-presented ternary complex is more stable and controls drug release. The components of the complex intensify interactions with bacterial membranes and increase the drug’s availability inside bacterial cells, thereby improving its antimicrobial efficacy and safety profile. Multifunctional antibiotics, formulated as drug delivery systems per se, that take the drug to the site of action, maximize its efficacy, and provide optical detectability are envisaged as the future in fighting against infections. Their role as a tool against multiresistant strains remains as interesting challenge open for further research., The authors are grateful to Angel Blanco Blanes and Dr. Samuel Sanchez from the Smart Nano-Bio-Devices group at the Institute for Bioengineering of Catalonia for zeta potential measurements as well as to Dr Dušan Žigon from Center for Mass Spectrometry at Jozef Stefan Institute for ToF MS analysis. The European Commission has funded this work under Horizon 2020’s Marie Skłodowska-Curie Actions COFUND scheme (Grant Agreement no. 712754) and by the Severo Ochoa program of the Spanish Ministry of Science and Competitiveness (Grant SEV-2014-0425 (2015-2019)). E.T. was supported by grants from the Spanish Ministerio de Economia y Competitividad (MINECO/FEDER) (RTI2018-098573-B-100), Generalitat de Catalunya (2017SGR-1079 and CERCA program), the Catalan Cystic Fibrosis associations and the La Caixa Foundation. Additional funding support has been provided to M.V. by grants from the Slovenian Research Agency (ARRS) (grants J2-8169, N2-0150, and P2-0091)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability

  • Vukomanovic, Marija
  • Gazvoda, Lea
  • Kurtjak, Mario
  • Hrescak, Jitka
  • Jaklic, Blaz
  • Moya, Laura
  • Cendra Gascón, María del Mar
  • Torrents Serra, Eduard
Designing useful functionalities in clinically validated, old antibiotics holds promise to provide the most economical solution for the global lack of effective antibiotics, as undoubtedly a serious health threat. Here we show that using the surface chemistry of the cyclodextrin (ßCD) cycle and arginine (arg) as a linker, provides more stable ternary antibiotic complex (ßCD-arg-cpx). In contrast to classical less stable inclusion complexes, which only modify antibiotic solubility, here-presented ternary complex is more stable and controls drug release. The components of the complex intensify interactions with bacterial membranes and increase the drug’s availability inside bacterial cells, thereby improving its antimicrobial efficacy and safety profile. Multifunctional antibiotics, formulated as drug delivery systems per se, that take the drug to the site of action, maximize its efficacy, and provide optical detectability are envisaged as the future in fighting against infections. Their role as a tool against multiresistant strains remains as interesting challenge open for further research., The authors are grateful to Angel Blanco Blanes and Dr. Samuel Sanchez from the Smart Nano-Bio-Devices group at the Institute for Bioengineering of Catalonia for zeta potential measurements as well as to Dr Dušan Žigon from Center for Mass Spectrometry at Jozef Stefan Institute for ToF MS analysis. The European Commission has funded this work under Horizon 2020’s Marie Skłodowska-Curie Actions COFUND scheme (Grant Agreement no. 712754) and by the Severo Ochoa program of the Spanish Ministry of Science and Competitiveness (Grant SEV-2014-0425 (2015-2019)). E.T. was supported by grants from the Spanish Ministerio de Economia y Competitividad (MINECO/FEDER) (RTI2018-098573-B-100), Generalitat de Catalunya (2017SGR-1079 and CERCA program), the Catalan Cystic Fibrosis associations and the La Caixa Foundation. Additional funding support has been provided to M.V. by grants from the Slovenian Research Agency (ARRS) (grants J2-8169, N2-0150, and P2-0091), Postprint (published version)
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

BCG Substrains Change Their Outermost Surface as a Function of Growth Media

  • Guallar Garrido, Sandra|||0000-0002-9666-5757
  • Almiñana-Rapún, Farners
  • Campo Pérez, Víctor|||0000-0003-3161-9984
  • Torrents, Eduard|||0000-0002-3010-1609
  • Luquin Fernandez, Marina de la Milagrosa|||0000-0002-6015-3282
  • Julián, Esther|||0000-0002-6558-3978
Mycobacterium bovis bacillus Calmette-Guérin (BCG) efficacy as an immunotherapy tool can be influenced by the genetic background or immune status of the treated population and by the BCG substrain used. BCG comprises several substrains with genetic differences that elicit diverse phenotypic characteristics. Moreover, modifications of phenotypic characteristics can be influenced by culture conditions. However, several culture media formulations are used worldwide to produce BCG. To elucidate the influence of growth conditions on BCG characteristics, five different substrains were grown on two culture media, and the lipidic profile and physico-chemical properties were evaluated. Our results show that each BCG substrain displays a variety of lipidic profiles on the outermost surface depending on the growth conditions. These modifications lead to a breadth of hydrophobicity patterns and a different ability to reduce neutral red dye within the same BCG substrain, suggesting the influence of BCG growth conditions on the interaction between BCG cells and host cells.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genomic analysis of Mycobacterium brumae sustains its nonpathogenic and immunogenic phenotype

  • Renau-Mínguez, Chantal
  • Herrero Abadía, Paula|||0000-0001-9747-1818
  • Ruiz-Rodriguez, Paula
  • Sentandreu, Vicente
  • Torrents, Eduard|||0000-0002-3010-1609
  • Chiner-Oms, Álvaro|||0000-0002-0463-0101
  • Torres-Puente, Manuela|||0000-0002-8352-180X
  • Comas, I.|||0000-0001-5504-9408
  • Julián, Esther|||0000-0002-6558-3978
  • Coscolla, Mireia
Mycobacterium brumae is a rapid-growing, non-pathogenic Mycobacterium species, originally isolated from environmental and human samples in Barcelona, Spain. Mycobacterium brumae is not pathogenic and it's in vitro phenotype and immunogenic properties have been well characterized. However, the knowledge of its underlying genetic composition is still incomplete. In this study, we first describe the 4 Mb genome of the M. brumae type strain ATCC 51384 T assembling PacBio reads, and second, we assess the low intraspecies variability by comparing the type strain with Illumina reads from three additional strains. Mycobacterium brumae genome is composed of a circular chromosome with a high GC content of 69.2% and containing 3,791 CDSs, 97 pseudogenes, one prophage and no CRISPR loci. Mycobacterium brumae has shown no pathogenic potential in in vivo experiments, and our genomic analysis confirms its phylogenetic position with other non-pathogenic and rapid growing mycobacteria. Accordingly, we determined the absence of virulence-related genes, such as ESX-1 locus and most PE/PPE genes, among others. Although the immunogenic potential of M. brumae was proved to be as high as Mycobacterium bovis BCG, the only mycobacteria licensed to treat cancer, the genomic content of M. tuberculosis T cell and B cell antigens in M. brumae genome is considerably lower than those antigens present in M. bovis BCG genome. Overall, this work provides relevant genomic data on one of the species of the mycobacterial genus with high therapeutic potential.